Encrypted | Login

Radiopharmaceutical Therapy Subcommittee (RPTSC)

AAPM Members, Affiliates and Non-Member Affiliates - Login for access to additional information

Activities
  1. Consolidate, disseminate and maintain available information concerning RPT methodologies, dosimetry, science and practice.
  2. Establish structures needed for providing guidelines and Standard Operating Procedures (SOPs) for new and existing RPTs such as Task Groups, Working Groups or MPPGs.
  3. Take an active role in the education of the AAPM and general radiation oncology community regarding RPT methodologies and clinical practice.
  4. Coordinate with stakeholder groups within AAPM, advising them of overlaps and seeking mutual solutions where needed.  
  5. Coordinate with stakeholder groups outside of AAPM to develop uniform and effective approaches to common problems with regard to RPT. These may include: SNMMI, EANM, ASTRO, ESTRO, ICRU, IAEA, ICRP, ABS, NIST, FDA, IROC, NRC, DOE.
By-Laws:Not Referenced.Rules: Not Referenced.
Approved Date(s):2/25/2021
Committee Keywords: No Keywords Entered
Chair

Robert Hobbs
Subcommittee Chair

2023 Roster

(dates shown below are start and end dates of position.)

= complete and up-to-date
= up-to-date but expires soon
= incomplete or out of date conflict of interest statement.

VOTING AppointmentsThere are 13 voting members.

up-to-dateDiane Alvarez, MS

1/1/2022 - 12/31/2024 Member
up-to-dateBryan Bednarz, PhD

2/25/2021 - 12/31/2023 Subcommittee Vice Chair

up-to-dateWesley E. Bolch, PhD

2/25/2021 - 12/31/2023 Member
up-to-dateJessica Clements, MS

2/25/2021 - 12/31/2023 Member

up-to-dateYuni K. Dewaraja

5/15/2022 - 12/31/2023 Chair,  Task Group No. 381 - AAPM Recommendations on imaging, dosimetry and quality assu (ex officio)
up-to-dateStephen A. Graves Ph.D.

2/25/2021 - 12/31/2023 Member

up-to-dateBennett S. Greenspan, MD

2/25/2021 - 12/31/2023 Member
up-to-dateRobert F. Hobbs, PhD

2/25/2021 - 12/31/2023 Subcommittee Chair

up-to-dateMelissa Carol Martin, MS

2/25/2021 - 12/31/2023 Member
up-to-dateNichole M. Maughan, PhD

3/30/2023 - 12/31/2025 Chair,   Working Group on Iodine-131 Radiopharmaceutical Therapies (WGI131) (ex officio)

up-to-dateOsama R. Mawlawi, PhD

6/13/2023 - 12/31/2025 Member
up-to-dateZoubir Ouhib, MS

2/25/2021 - 12/31/2023 Member

up-to-dateReed G. Selwyn, PhD

5/25/2023 - 12/31/2025 Chair,  Working Group on Radioactive Microspheres (ex officio)
NON-VOTING AppointmentsThere are 14 non-voting members and guests.

up-to-dateEthan Balkin

1/1/2022 - 12/31/2023 Liaison - DOE (nonvoting)
up-to-dateDenis Bergeron

1/1/2022 - 12/31/2023 Liaison - NIST (nonvoting)

up-to-dateBette W. Blankenship, MS

2/25/2021 - 12/31/2023 Guest (nonvoting)
up-to-dateJacek Capala, PhD

2/25/2021 - 12/31/2023 Liaison - NIH/NCI (ex officio, nonvoting)

up-to-dateBruce H. Curran, MEng

1/1/2023 - 12/31/2023 Guest (nonvoting)
up-to-dateJonathan Gear

1/1/2022 - 12/31/2023 Liaison - Royal Madsen/EANM (nonvoting)

up-to-dateKathleen M. Hintenlang, PhD

1/1/2023 - 12/31/2023 Guest (nonvoting)
up-to-datePeter Knoll Ph.D.

2/25/2021 - 12/31/2023 Liaison - IAEA (ex officio, nonvoting)

up-to-dateDonika Plyku Ph.D.

1/1/2023 - 12/31/2023 Guest (nonvoting)
up-to-dateJohn Sunderland Ph.D.

1/1/2023 - 12/31/2023 Liaison - SNMMI (ex officio, nonvoting)

up-to-dateKatherine N. Tapp, PhD

2/1/2022 - 12/31/2023 Liaison - NRC (nonvoting)
up-to-dateGerald A. White Jr., MS

2/1/2022 - 12/31/2023 Liaison (nonvoting)

up-to-dateYing Xiao, PhD

2/25/2021 - 12/31/2023 Liaison - IROC (ex officio, nonvoting)
up-to-dateBrian E. Zimmerman

2/1/2022 - 12/31/2023 Liaison - NIST (nonvoting)
HQ Team Appointed to CommitteeThere are 1 staff.

up-to-dateDavid P. Crowley

6/15/2023 - 12/31/2037 Senior Government Relations Manager (ex officio, nonvoting)



See connections to Radiopharmaceutical Therapy Subcommittee